Metabolite profiling and pathway analysis of acute hepatitis rats by UPLC-ESI MS combined with pattern recognition methods

Liver International

Volumn 34, Issue 5, 2014, Pages 759-770

  Wang, Xijun ^a   Lv, Haitao ^a   Zhang, Aihua ^a   Sun, Wenjun ^a   Liu, Lian ^a   Wang, Ping ^a   Wu, Zeming ^a   Zou, Dixin ^a   Sun, Hui ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

D galactosamine; Hepatitis; Metabolite; Metabolomics; Pattern recognition methods; UPLC ESI MS

Indexed keywords

AFALANINE; BETA HYDROXYBUTANOIC ACID; BUTYRIC ACID; CHOLIC ACID; CITRIC ACID; CREATININE; GALACTOSAMINE; GLYCOCHOLIC ACID; INDOLEACETIC ACID; SPHINGANINE; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL CHEMISTRY; CONTROLLED STUDY; CREATININE URINE LEVEL; ELECTROSPRAY MASS SPECTROMETRY; ENERGY METABOLISM; HISTOPATHOLOGY; LIPID METABOLISM; LIVER HISTOLOGY; MALE; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; NONHUMAN; PATTERN RECOGNITION; PHENOTYPE; RAT; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY ELECTROSPRAY MASS SPECTROMETRY; URINALYSIS; URINARY EXCRETION; ANIMAL; ANIMAL HEPATITIS; BLOOD; LIQUID CHROMATOGRAPHY; METABOLOME; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS; URINE; WISTAR RAT;

ANIMALS; CHROMATOGRAPHY, LIQUID; HEPATITIS, ANIMAL; MALE; METABOLOME; PRINCIPAL COMPONENT ANALYSIS; RATS, WISTAR; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84897962522     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12301     Document Type: Article

References (33)

1. Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature 2008; 455: 1054-6.
2. Wang X, Zhang A, Sun H. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma. Hepatology 2013; 57: 2072-7.
3. Arakaki AK, Skolnick J, McDonald JF. Marker metabolites can be therapeutic targets as well. Nature 2008; 456: 443.
4. Williams HR, Cox IJ, Taylor-Robinson SD. Metabonomics in hepatic encephalopathy: lucidity emerging from confusion. Liver Int 2008; 28: 1050-1.
5. Sun H, Zhang A, Yan G, et al. Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews. Mol Cell Proteomics 2013; 12: 710-9.
6. Zhang A, Sun H, Han Y, et al. Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach. Analyst 2012; 137: 4200-8.
7. Wang X, Zhang A, Han Y, et al. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics 2012; 11: 370-80.
8. Wang X, Yang B, Sun H, Zhang A. Pattern recognition approaches and computational systems tools for ultra performance liquid chromatography-mass spectrometry-based comprehensive metabolomic profiling and pathways analysis of biological data sets. Anal Chem 2012; 84: 428-39.
9. Barba I, Chatauret N, García-Dorado D, Córdoba JA. 1H nuclear magnetic resonance-based metabonomic approach for grading hepatic encephalopathy and monitoring the effects of therapeutic hypothermia in rats. Liver Int 2008; 28: 1141-8.
10. Maher AD, Coles C, White J, et al. 1H NMR spectroscopy of serum reveals unique metabolic fingerprints associated with subtypes of surgically induced osteoarthritis in sheep. J Proteome Res 2012; 11: 4261-8.
11. Hong Z, Lin Z, Liu Y, et al. Innovative microwave-assisted oximation and silylation procedures for metabolomic analysis of plasma samples using gas chromatography-mass spectrometry. J Chromatogr A 2012; 1254: 14-22.
12. Zhang A, Sun H, Wang P, Han Y, Wang X. Modern analytical techniques in metabolomics analysis. Analyst 2012; 137: 293-300.
13. Wang X, Yang B, Zhang A, Sun H, Yan G. Potential drug targets on insomnia and intervention effects of Jujuboside A through metabolic pathway analysis as revealed by UPLC/ESI-SYNAPT-HDMS coupled with pattern recognition approach. J Proteomics 2012; 75: 1411-27.
14. Tripathi LP, Kataoka C, Taguwa S, et al. Network based analysis of hepatitis C virus core and NS4B protein interactions. Mol BioSyst 2010; 6: 2539-53.
15. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461: 798-801.
16. Roth J, Wang Y, Eckhardt AE, Hill RL. Subcellular localization of the UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-mediated O-glycosylation reaction in the submaxillary gland. Proc Natl Acad Sci U S A. 1994; 91: 8935-9.
17. Li G, Chen W, Han C, Wu T. Cytosolic phospholipase A(2)α protects against Fas- but not LPS-induced liver injury. J Hepatol 2011; 55: 1281-90.
18. Zheng S, Sanada H, Dohi H, Hirai S, Egashira Y. Suppressive effect of modified arabinoxylan from rice bran (MGN-3) on D-galactosamine-induced IL-18 expression and hepatitis in rats. Biosci Biotechnol Biochem 2012; 76: 942-6.
19. Sun F, Hamagawa E, Tsutsui C, et al. Evaluation of oxidative stress during apoptosisandnecrosiscausedby d-galactosamine in rat liver. Biochem Pharmacol 2003; 65: 101-7.
20. Zhang A, Sun H, Han Y, Yan G, Wang X. Urinary metabolic biomarker and pathway study of hepatitis B Virus infected patients based on UPLC-MS system. PLoS ONE 2013; 8: e64381.
21. Zhang AH, Sun H, Qiu S, Wang XJ. Metabolomics in noninvasive breast cancer. Clin Chim Acta 2013; 424C: 3-7.
22. Wang X, Zhang A, Wang P, et al. Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies. Mol Cell Proteomics 2013; 12: 1226-38.
23. Feng B, Wu S, Lv S, et al. Metabolic profiling analysis of a D-Galactosamine/Lipopolysaccharide-induced mouse model of fulminant hepatic failure. J Proteome Res 2007; 6: 2161-7.
24. Beckwith-Hall BM, Nicholson JK, Nicholls AW, et al. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem Res Toxicol 1998; 11: 260-72.
25. Papagianni M. Advances in citric acid fermentation by Aspergillus niger: biochemical aspects, membrane transport and modeling. Biotechnol Adv 2007; 25: 244-63.
26. Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev 2000; 80: 1107-213.
27. Wang YL, Tang HR, Nicholson JK, et al. A metabonomic strategy for the detection of the metabolic effects of chamomile (Matricaria recutita L.) ingestion. J Agric Food Chem 2005b; 53: 191-6.
28. Schlattner U, Tokarska-Schlattner M, Wallimann T. Mitochondrial creatine kinase in human health and disease. Biochim Biophys Acta-Bioenerg 2006; 1762: 164-80.
29. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med 1989; 321: 1014-22.
30. Rost D, Herrmann T, Sauer P, et al. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis:effect of ursodeoxycholate. Hepatology 2003; 38: 187-95.
31. Collazos J. Glycocholic acid in chronic active hepatitis and mild liver diseases. J Mol Med 1993; 72: 36-9.
32. Price VF, Jollow DJ. Mechanism of ketone-induced protection from acetaminophen hepatotoxicity in the rat. Drug Metab Dispos 1983; 11: 451-7.
33. Michel C, Beatriz T, Gabriel LP. Acetone potentiation of chronic liver injury induced by repetitive administration of carbon tetrachloride. Hepatology 2005; 6: 94-700.